felin
coronaviru
fcov
posit
strand
rna
viru
ubiquit
multicat
environ
breed
catteri
rescu
shelter
cat
sanctuari
larg
cat
zoo
rare
stray
feral
cat
fcov
primarili
pathogen
gastrointestin
tract
domest
cat
replic
intestin
spread
faecalor
transmiss
cat
either
persist
transient
infect
addi
et
al
addi
et
al
fcov
infect
often
subclin
may
result
number
problemat
condit
acut
chronic
diarrhoea
stunt
kitten
transient
upper
respiratori
sign
newli
infect
kitten
cat
faecal
incontin
persist
infect
carrier
cat
addi
jarrett
kipar
et
al
fcov
rna
found
five
cat
chronic
caecocol
diseas
although
unclear
fcov
caus
lesion
hahn
et
al
cat
acquir
infect
typic
addi
et
al
develop
felin
infecti
periton
fip
recent
consid
almost
uniformli
fatal
diseas
howev
major
advanc
pedersen
et
al
found
recent
fip
cure
parenter
administr
novel
antivir
nucleosid
analogu
drug
yet
licens
veterinari
use
sever
product
specif
describ
other
proprietari
name
sold
internet
cat
guardian
treat
cat
suffer
fip
fcov
persist
multicat
household
infect
reinfect
healthi
cat
anoth
strain
viru
develop
persist
infect
carrier
statu
fcovinfect
cat
act
reservoir
infect
felin
popul
without
develop
fip
addi
et
al
addi
et
al
addi
et
al
herrewegh
et
al
urgent
need
method
prevent
cat
high
densiti
environ
breed
rescu
catteri
becom
infect
fcov
fip
vaccin
licens
countri
first
dose
administ
week
gerber
et
al
late
protect
kitten
usual
infect
matern
deriv
antibodi
wane
week
age
addi
jarrett
pedersen
et
al
present
therefor
major
way
prevent
fip
prevent
exposur
viru
quarantin
rigor
hygien
fcov
transmiss
faecalor
share
litter
tray
fcov
shedder
fomit
transmiss
major
risk
factor
uninfect
cat
dri
indoor
environ
fcov
surviv
seven
week
fomit
scott
anoth
method
control
would
stop
excret
viru
faec
infect
cat
antivir
therapi
cat
guardian
consid
whether
drug
shown
cure
fip
might
also
stop
asymptomat
fcovinfect
cat
shed
viru
therebi
prevent
act
sourc
infect
provid
mean
establish
household
cat
free
viru
x
nantong
mutian
biotechnolog
co
ltd
china
one
product
formul
capsul
contain
nicotinamid
mononucleotid
crocin
sadenosylmethionin
silymarin
mutian
x
novel
synthet
adenosin
analogu
patent
pend
china
exhibit
broadspectrum
activ
rna
virus
toni
xue
ceo
nantong
person
commun
nucleosid
analogu
function
replac
adenosin
thu
termin
replic
rna
viru
genom
mutian
x
efficaci
oral
rout
unlik
previous
describ
anti
coronaviru
drug
must
given
pain
inject
often
caus
sever
inflammatori
respons
pedersen
et
al
concern
develop
felin
inject
site
sarcoma
although
recombin
felin
interferon
omega
virbagen
omega
virbac
franc
previous
shown
reduc
fcov
shed
first
report
document
antivir
stop
excret
fcov
faec
natur
infect
cat
fcov
test
implement
household
experienc
fip
amongst
cat
summari
cat
reason
screen
fcov
shed
shown
tabl
thirtyfour
cat
five
multicat
household
ae
natur
infect
fcov
treat
mutian
x
result
five
cat
household
e
could
includ
interv
faecal
test
left
possibl
cat
might
spontan
stop
shed
viru
rather
mutian
x
stop
viru
shed
thu
exclud
treatment
control
group
tabl
therefor
remain
data
cat
treat
mutian
x
household
c
ragdol
breed
catteri
histori
endem
fcov
least
year
despit
test
fcov
antibodi
shed
rigor
hygien
catteri
experienc
eight
fip
death
keep
cat
small
group
singli
attempt
prevent
fcov
transmiss
result
clearanc
viru
eight
cat
prior
observ
studi
report
catteri
owner
sc
discov
could
reduc
coronaviru
shed
cat
use
mutian
x
tablet
work
optimis
dose
durat
treatment
stop
viru
shed
faecal
sampl
mail
veterinari
diagnost
laboratori
vdl
univers
glasgow
uk
sampl
mail
use
royal
mail
fedex
ice
rnapreserv
buffer
cat
guardian
advis
tri
submit
faecal
sampl
cat
litter
attach
sinc
cat
litter
inhibit
pcr
reaction
perform
duplic
perform
fcov
rtqpcr
test
blind
treatment
cat
receiv
threshold
cycl
ct
number
use
measur
viral
load
lower
ct
viru
present
sampl
sampl
signal
c
consid
neg
cat
guardian
purchas
mutian
x
onlin
mutian
x
avail
either
tablet
format
contain
antivir
mutian
x
ingredi
capsul
mutian
x
contain
exact
natur
mutian
x
commerci
secret
prior
chines
patent
grant
manufactur
describ
adenosin
nucleosid
analogu
toni
xue
person
commun
cat
guardian
use
hour
per
os
seven
day
per
advic
social
media
group
stop
fcov
shed
owner
household
c
sc
experi
differ
dose
protocol
aim
minimis
dose
durat
treatment
stop
faecal
viru
shed
report
outcom
use
mgkg
dose
owner
household
e
fb
bc
set
camera
alarm
system
enabl
record
exact
number
hour
post
onset
treatment
faecal
sampl
pass
ensur
sampl
contamin
degrad
prior
use
mutian
x
cat
guardian
attempt
prevent
fcov
transmiss
within
household
quarantin
fip
cat
household
keep
cat
small
group
possibl
given
facil
household
c
e
use
dr
elsey
cat
attract
cat
litter
bentonitebas
cat
litter
household
e
respect
household
also
tri
reduc
fcov
shed
use
probiot
recombin
day
cours
itraconazol
household
shown
vitro
activ
type
fcov
takano
et
al
variou
treatment
group
singl
control
period
household
fig
sinc
number
cat
paramet
small
statist
signific
also
combin
prevent
strategi
use
observ
studi
opportun
conduct
placebocontrol
trial
howev
fcov
shed
record
prior
treatment
mutian
x
avail
use
retrospect
control
period
cat
act
control
meant
variabl
hous
breed
age
affect
fcov
shed
constant
fisher
exact
test
twotail
correl
coeffici
carri
use
statist
packag
excel
microsoft
offic
result
summaris
tabl
prior
studi
owner
household
c
attempt
variou
mutian
x
treatment
regim
cat
singl
dose
treatment
attempt
two
cat
viru
load
reduc
fail
clear
infect
viru
load
increas
cat
cat
given
singl
inject
mutian
three
day
prior
oral
treatment
reduc
viru
shed
c
thu
singl
dose
ineffect
clear
infect
may
risk
emerg
resist
virus
ten
cat
receiv
full
cours
two
cat
began
increas
eight
ten
cat
stop
shed
fcov
use
mutian
x
tablet
dose
sid
fig
seven
four
day
two
probabl
fcov
carrier
cat
shed
viru
level
c
c
year
prior
treatment
treat
day
dose
faec
neg
remain
neg
test
five
seven
day
later
remain
cat
treat
four
day
shown
fig
tabl
daili
sampl
avail
five
cat
two
clear
viru
within
hour
three
hour
cat
test
daili
accur
time
cessat
viru
shed
could
determin
cat
fail
total
clear
viru
use
dose
day
therefor
treat
becam
neg
shown
fig
tabl
cat
group
began
shed
viru
within
day
requir
second
cours
treatment
fig
two
cat
start
treatment
sid
chang
higher
dose
within
hour
due
result
household
c
fig
cat
therefor
includ
rather
categori
summari
mutian
x
dose
consid
inadequ
clear
viru
eight
cat
reduc
abrog
viru
shed
two
cat
fig
thereaft
dose
increas
dose
reliabl
clear
viru
within
seven
day
cat
two
cat
household
one
household
b
household
c
household
e
cat
cat
fail
clear
viru
six
day
cours
dose
vomit
capsul
requir
repeat
cours
three
day
neg
ten
cat
receiv
full
cours
mutian
x
eight
cat
clear
infect
cat
cat
hous
began
shed
viru
therefor
end
part
studi
cat
clear
viru
three
requir
retreat
twentytwo
cat
receiv
cours
mutian
x
dose
cat
becam
neg
cat
vomit
capsul
requir
treatment
becam
neg
thu
cat
clear
infect
four
cat
requir
second
cours
treatment
determin
whether
cat
shed
higher
amount
viru
requir
day
antivir
treatment
cat
lower
viru
quantiti
start
fcov
rna
c
plot
day
becom
neg
serial
accur
time
daili
faecal
sampl
avail
cat
fig
clear
viru
within
hour
start
treatment
correl
start
fcov
rna
c
time
becom
neg
found
pretreat
viru
shed
record
use
retrospect
control
observ
studi
fcov
viru
shed
result
prior
mutian
x
administr
avail
treat
cat
shown
tabl
two
addit
cat
household
c
spontan
stop
shed
viru
prior
start
treatment
period
data
shown
one
cat
kept
isol
one
allow
outdoor
therefor
two
cat
stop
shed
viru
control
period
differ
number
cat
stop
shed
viru
control
period
subsequ
mutian
x
statist
signific
p
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
repeat
neg
sampl
avail
six
cat
dose
cat
dose
tabl
cat
dose
remain
neg
least
day
day
respect
first
neg
result
show
cat
remain
neg
posttreat
start
spontan
shed
viru
fcov
antibodi
titr
avail
cat
five
month
posttreat
reduc
respect
mutian
x
pill
stop
faecal
fcov
shed
natur
infect
cat
howev
four
cat
requir
second
cours
treatment
viru
elimin
sinc
success
treatment
fip
use
antivir
drug
first
report
pedersen
et
al
pedersen
et
al
cat
guardian
abl
sourc
variou
antifcov
drug
includ
mutian
x
via
social
media
view
prefer
propos
use
medic
even
though
product
unlicens
proper
veterinari
guidanc
rather
follow
advic
social
media
group
moder
howev
knowledg
professor
pedersen
provid
lucid
view
current
situat
relat
treatment
cat
fip
black
market
drug
subsequ
dilemma
veterinari
surgeon
http
paraphras
professor
niel
pedersen
would
prefer
drug
approv
licens
made
avail
normal
manner
rather
sold
black
market
will
advis
veterinari
surgeon
client
advic
fip
experi
like
reduc
unnecessari
use
anticoronaviru
drug
two
five
household
report
fip
therapi
level
antivir
treatment
begun
two
cat
fip
ceas
proper
diagnosi
obtain
antivir
treatment
stop
nine
misdiagnos
cat
da
person
observ
present
observ
studi
cat
guardian
use
mutian
x
stop
cat
shed
viru
defin
protocol
optimis
minimis
use
furthermor
hope
stop
cat
shed
fcov
especi
purebr
cat
preval
fip
reduc
reduc
use
unlicens
drug
four
day
cours
mutian
x
dose
clear
coronaviru
eight
cat
fail
clear
infect
cat
opinion
leader
express
concern
use
mutian
x
stop
viru
shed
cat
without
fip
lead
drug
resist
failur
drug
treat
fip
although
abil
mutian
x
treat
fip
actual
yet
document
far
awar
ask
hold
view
consid
follow
first
drug
alreadi
use
purpos
viru
elimin
cat
guardian
sure
better
proper
protocol
develop
rather
left
trial
error
second
found
intens
four
day
cours
stop
viru
shed
cat
treat
fip
higher
viru
load
kipar
et
al
requir
longer
cours
treatment
week
pedersen
et
al
sure
like
allow
resist
viru
strain
develop
inde
viru
resist
nucleosid
analogu
document
cat
treat
fip
pedersen
et
al
antivir
use
prophylact
viral
infect
preced
approach
found
evid
develop
drug
resist
asymptomat
cat
dose
view
treat
breed
queen
four
day
stop
fcov
shed
less
like
induc
drug
resist
treat
least
one
ten
kitten
fip
requir
week
medic
howev
treatment
viru
shed
cat
must
done
properli
one
concern
cat
guardian
may
tempt
reduc
cost
use
insuffici
dose
durat
treatment
sc
person
observ
might
result
select
virus
resist
mutian
x
anoth
concern
blunderbuss
approach
may
taken
treat
cat
household
without
first
confirm
viru
shedder
correl
found
fcov
rna
c
prior
treatment
time
becom
neg
therefor
cat
shed
viru
requir
longer
treatment
cours
cat
shed
lower
amount
viru
day
cours
like
suffic
rather
day
sinc
studi
observ
rather
prospect
formal
placebo
group
lack
placebo
group
studi
problemat
could
argu
cat
spontan
stop
shed
fcov
coincident
onset
mutian
x
therapi
said
unlik
cat
would
ceas
viru
shed
coincident
within
day
begin
mutian
x
treatment
retrospect
compar
result
prior
mutian
x
viru
erad
attempt
quarantin
hygien
itraconazol
without
probiot
anoth
argument
might
cat
stop
shed
viru
delay
result
treatment
given
cat
prior
mutian
x
argument
could
appli
household
b
c
e
cat
receiv
treatment
howev
household
viru
load
decreas
two
cat
probiot
fortiflora
purina
pro
plan
usa
remain
constant
level
third
cat
therefor
combin
interferon
probiot
may
reduc
fcov
shed
previous
shown
reduc
stop
fcov
shed
gil
et
al
probiot
routin
use
treat
children
viral
diarrhoea
szajewska
et
al
interact
gut
microbiom
fcov
extens
explor
meazzi
et
al
investig
possibl
probiot
might
reduc
coronaviru
load
warrant
cat
household
also
receiv
itraconazol
shown
invitro
activ
fcovi
takano
et
al
howev
day
cours
treatment
fail
clear
three
cat
fcov
although
viral
rna
quantiti
decreas
cat
itraconazol
bounc
back
immedi
stop
anoth
possibl
mutian
x
could
excret
faec
inhibit
fcov
rtqpcr
assay
unlik
shown
fig
fcov
rna
detect
cat
mutian
x
treatment
also
faecal
sampl
remain
neg
cat
ceas
mutian
x
fourday
cours
mutian
x
tablet
appear
effect
stop
fcov
shed
daili
monitor
faecal
fcov
shed
use
laboratori
rapidli
report
viru
quantiti
necessari
tailor
treatment
durat
accord
circumst
individu
cat
viru
highli
contagi
cat
share
litter
tray
rapidli
reinfect
experi
household
c
e
larg
number
cat
even
though
kept
small
group
household
c
reinfect
cat
occur
less
day
hous
one
cat
fail
clear
viru
dose
mutian
x
cat
litter
use
sawdust
base
could
argu
cat
shed
viru
intermitt
hous
group
fail
clear
viru
dose
thu
far
like
reinfect
latent
infect
intermitt
viru
shed
seen
cat
trial
previou
studi
sequenti
test
hundr
cat
use
modern
sensit
fcov
rtqpcr
technolog
addi
unpublish
observ
control
fals
neg
result
due
faecal
pcr
inhibitor
dye
et
al
experi
cat
either
shed
viru
continu
stop
shed
viru
appear
intermitt
viru
shed
could
alway
trace
back
exposur
faec
infect
cat
viru
quantiti
low
borderlin
abil
assay
detect
presenc
excess
cat
litter
sampl
fuller
earth
base
cat
litter
bind
organ
materi
side
effect
mutian
x
observ
us
one
cat
initi
vomit
capsul
might
advers
reaction
although
cat
nt
vomit
subsequ
capsul
howev
mean
mutian
x
without
side
effect
elev
liver
enzym
seen
cat
fip
treat
mani
week
dda
unpublish
observ
use
laboratori
adequ
sensit
fcov
rtqpcr
test
absolut
essenti
detect
erad
fcov
household
fals
neg
result
doom
effort
failur
six
eight
sampl
sent
one
highli
reput
univers
veterinari
laboratori
fals
report
neg
data
shown
major
problem
identifi
studi
delay
report
fcov
rtqpcr
resultsusu
least
one
week
date
sampl
submissiondelay
separ
neg
posit
cat
allow
reinfect
cat
clear
infect
studi
show
oral
administr
mutian
x
tablet
dose
four
day
stop
shed
fcov
natur
infect
cat
treatment
would
use
adjunct
establish
fcovfre
household
cat
addit
current
measur
hygien
hous
cat
small
group
use
virusinhibit
cat
litter
addi
et
al
observ
cat
stop
shed
viru
determin
whether
mutian
x
prevent
develop
fip
also
serum
antifcov
titr
treat
cat
declin
come
year
indic
viru
clear
system
well
gastrointestin
tract
graph
record
faecal
fcov
rna
detectionrtqpcr
c
shown
axi
time
day
x
axi
three
cat
time
point
indic
faecal
test
graph
normalis
time
zero
test
period
mutian
x
start
mutian
x
given
day
day
cat
faecal
sampl
remain
neg
day
x
axi
show
day
graph
show
intermitt
viru
shed
reinfect
occur
faecal
fcov
rna
detectionrtqpcr
c
shown
axi
time
day
x
axi
ten
cat
treat
mutian
x
oral
dose
sid
fig
eleven
cat
dose
sid
fig
time
point
indic
faecal
test
graph
normalis
time
zero
start
mutian
x
treatment
cut
day
prior
test
exact
extent
treatment
control
period
indic
tabl
two
cat
fail
clear
infect
dose
fig
treat
fig
cat
kept
group
cat
becam
reinfect
requir
retreat
cat
also
featur
figur
aim
scatter
plot
determin
whether
cat
shed
higher
amount
viru
requir
day
antivir
treatment
cat
lower
viru
quantiti
daili
monitor
faec
avail
cat
result
c
two
overlaid
give
appear
sampl
although
slight
inclin
trendlin
correl
start
fcov
rna
c
day
neg
result
prior
studi
immunohistochemistri
perform
confirm
diagnosi
fip
suspect
second
cat
mutian
treatment
begun
multicentr
lymphoma
antivir
drug
stop
cat
divid
three
group
eight
cat
cat
becam
infect
studi
period
despit
clump
bentonitebas
cat
litter
use
result
infect
cat
could
count
stop
shed
due
mutian
x
absenc
faecal
sampl
immedi
prior
mutian
x
treatment
therefor
possibl
ceas
shed
viru
prior
onset
treatment
howev
also
possibl
stop
shed
viru
within
hour
treatment
fcov
po
fcov
shed
faec
time
mutian
treatment
part
studi
